Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvana Novelli

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Cancers|November 26, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish GroupsBeatriz Rey-Búa, Mónica Cabrero, Leyre Bento, et al.
Haematologica|May 30, 2013
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapyAlexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, et al.
British Journal of Haematology|October 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcomeAna Muntañola, Pablo Mozas, Santiago Mercadal, et al.
Blood Cells, Molecules & Diseases|September 26, 2020
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patientsMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Clinical Nuclear Medicine|June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T CellsPierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab ExposureAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
Scientific Reports|November 15, 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopeniaMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Cancers|November 26, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish GroupsBeatriz Rey-Búa, Mónica Cabrero, Leyre Bento, et al.
Haematologica|May 30, 2013
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapyAlexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, et al.
British Journal of Haematology|October 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcomeAna Muntañola, Pablo Mozas, Santiago Mercadal, et al.
Blood Cells, Molecules & Diseases|September 26, 2020
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patientsMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Clinical Nuclear Medicine|June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T CellsPierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab ExposureAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
Scientific Reports|November 15, 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopeniaMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Pageof 7